BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 8923470)

  • 1. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
    Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
    Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes.
    Rosenbaum SE; Greenberg AS
    Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation.
    Hansen LH; Madsen B; Teisner B; Nielsen JH; Billestrup N
    Mol Endocrinol; 1998 Aug; 12(8):1140-9. PubMed ID: 9717840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired lipid accumulation by trans10, cis12 CLA during adipocyte differentiation is dependent on timing and length of treatment.
    Granlund L; Pedersen JI; Nebb HI
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):11-22. PubMed ID: 15708349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation.
    Kudo M; Sugawara A; Uruno A; Takeuchi K; Ito S
    Endocrinology; 2004 Nov; 145(11):4948-56. PubMed ID: 15284209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells.
    Nanbu-Wakao R; Fujitani Y; Masuho Y; Muramatu M; Wakao H
    Mol Endocrinol; 2000 Feb; 14(2):307-16. PubMed ID: 10674402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake.
    Hamm JK; el Jack AK; Pilch PF; Farmer SR
    Ann N Y Acad Sci; 1999 Nov; 892():134-45. PubMed ID: 10842659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis.
    Wauson EM; Langan AS; Vorce RL
    Toxicol Sci; 2002 Feb; 65(2):211-9. PubMed ID: 11812925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression.
    Xing H; Northrop JP; Grove JR; Kilpatrick KE; Su JL; Ringold GM
    Endocrinology; 1997 Jul; 138(7):2776-83. PubMed ID: 9202217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes.
    Kajita K; Ishizuka T; Mune T; Miura A; Ishizawa M; Kanoh Y; Kawai Y; Natsume Y; Yasuda K
    Endocrinology; 2003 Jan; 144(1):253-9. PubMed ID: 12488352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha inhibits 3T3-L1 adipocyte differentiation without downregulating the expression of C/EBPbeta and delta.
    Kurebayashi S; Sumitani S; Kasayama S; Jetten AM; Hirose T
    Endocr J; 2001 Apr; 48(2):249-53. PubMed ID: 11456275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes.
    Han J; Farmer SR; Kirkland JL; Corkey BE; Yoon R; Pirtskhalava T; Ido Y; Guo W
    J Nutr; 2002 May; 132(5):904-10. PubMed ID: 11983812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
    Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
    Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
    Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
    Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
    Tontonoz P; Hu E; Graves RA; Budavari AI; Spiegelman BM
    Genes Dev; 1994 May; 8(10):1224-34. PubMed ID: 7926726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.
    Szalkowski D; White-Carrington S; Berger J; Zhang B
    Endocrinology; 1995 Apr; 136(4):1474-81. PubMed ID: 7895657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes.
    Kong CS; Kim JA; Eom TK; Kim SK
    J Nutr Biochem; 2010 May; 21(5):438-43. PubMed ID: 19427183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells.
    Moreno-Aliaga MJ; Matsumura F
    Mol Pharmacol; 1999 Jul; 56(1):91-101. PubMed ID: 10385688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.